NEWS
Find a Professional: Explore Experts Across 197 Disciplines in 221 Countries!
Just Updated: Compare Your Institution (Live Data)
Print Your Certificate
New! Young University / Institution Rankings 2025
New! Art & Humanities Rankings 2025
New! Social Sciences and Humanities Rankings 2025
Highly Cited Researchers 2025 (Updated Today)
AD
Scientific Index 2025
Scientist Rankings
University Rankings
Subject Rankings
Country Rankings
Login
Register & Pricing
insights
H-Index Rankings
insights
i10 Productivity Rankings
format_list_numbered
Citation Rankings
subject
University Subject Rankings
school
Young Universities
format_list_numbered
Top 100 Scientists
format_quote
Top 100 Institutions
format_quote
Compare & Choose
local_fire_department
Country Reports
person
Find a Professional
Linda Harrison
Harvard University - Cambridge / United States
Medical and Health Sciences / Biostatistics
AD Scientific Index ID: 1391399
Registration, Add Profile,
Premium Membership
Print Your Certificate
Ranking &
Analysis
Job
Experiences (0)
Education
Information (0)
Published Books (0)
Book Chapters (0)
Articles (0)
Presentations (0)
Lessons (0)
Projects (0)
Co-Authors
Subject Leaders
Editorship, Referee &
Scientific Board (0 )
Patents /
Designs (0)
Academic Grants
& Awards (0)
Artistic
Activities (0)
Certificate / Course
/ Trainings (0)
Association &
Society Memberships (0)
Contact, Office
& Social Media
person_outline
Linda Harrison's MOST POPULAR ARTICLES
1-)
Effect of HIV antibody VRC01 on viral rebound after treatment interruption New England Journal of Medicine 375 (21), 2037-2050, 2016
2-)
Tenofovir to Prevent Perinatal Transmission of Hepatitis B. The New England journal of medicine 378 (24), 2350, 2018
3-)
Tenofovir versus placebo to prevent perinatal transmission of hepatitis B New England Journal of Medicine 378 (10), 911-923, 2018
4-)
Effect of HIV-1 subtype on virologic and immunologic response to starting highly active antiretroviral therapy Clinical infectious diseases 48 (9), 1296-1305, 2009
5-)
First-line antiretroviral therapy with a protease inhibitor versus non-nucleoside reverse transcriptase inhibitor and switch at higher versus low viral load in HIV-infected … The Lancet infectious diseases 11 (4), 273-283, 2011
ARTICLES
Add your articles
We use cookies to personalize our website and offer you a better experience. If you accept cookies, we can offer you special services.
Cookie Policy
Accept